Ribera A, Slof J, Andrea R, Falces C, Gutiérrez E, Del Valle-Fernández R, Morís-de la Tassa C, Mota P, Oteo JF, Cascant P, Altisent OA, Sureda C, Serra V, García-Del Blanco B, Tornos P, García-Dorado D, Ferreira-González I
Int. J. Cardiol.. 2015 Mar;182:321-8, PMID: 25585368
To evaluate cost-effectiveness of transfemoral TAVR vs surgical replacement (SAVR) and its determinants in patients with severe symptomatic aortic stenosis and comparable risk.
CARDIAC & CARDIOVASCULAR SYSTEMS